HCG (Human Chorionic Gonadotropin)
LH analogue that directly stimulates testicular Leydig cells to produce testosterone and maintain testicular volume. Half-life ~33 hours after IM/SC injection. Typically dosed at 250-500 IU 2-3x/week alongside TRT to preserve fertility and prevent testicular atrophy.
Projected serum levels — 500 IU (≈ 0.045 mg), twice weekly
Maintenance schedule: 500 IU (≈ 0.045 mg) twice weekly (im).
Loading schedule: 620 IU on day 1, then 500 IU (≈ 0.045 mg) twice weekly — reaching therapeutic levels sooner.
Modeled steady state after ~7 days: peak ≈ 0.024 mg, trough ≈ 0.007 mg body load. Population-based estimate over 18 days for a reference dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Gonadotropin
- Route modeled
- IM
- Model confidence
- inferred
- Half-life
- 36 h
- Common dose
- 500 IU (≈ 0.045 mg)
- Suggested maximum
- 2k IU/day
- Reference dose range
- 250–2k IU (single dose)
- Suggested cadence
- twice weekly
Research behind this entry
-
Disappearance of Exogenously Administered Human Chorionic Gonadotropin
Measured hCG disappearance (PMID:2776893) after IM injection in 34 IVF patients, finding exponential elimination with mean half-life of 2.32 days and levels detectable up to 14 days post-injection.
-
Pharmacodynamics and Pharmacokinetics after Subcutaneous and Intramuscular Injection of Human Chorionic Gonadotropin
Compared SC vs IM hCG injection (PMID:1712735), showing delayed peak and prolonged half-life with SC route, with peak serum levels at 6-12 h (IM) vs 16-20 h (SC).
2 published studies referenced in the app, each with a plain-language summary.